Quick Answer: EU cosmetic microbiological testing supports the product safety assessment; it is not a standalone market-approval certificate. Brands should distinguish the microbiological quality of a sample from the formula’s ability to resist contamination during use. The appropriate evidence depends on the formula, packaging, intended users and risk assessment. Agree the testing plan with a competent laboratory and safety assessor before committing to a launch.
Prepared for international beauty brands by MOOYAM. Last reviewed: 5 October 2026. Cover: AI-generated illustration, not a photograph of an actual test.
What is the regulatory purpose of microbiological testing?
The HPRA guidance on the cosmetic product safety report explains that the CPSR brings together safety information and a safety assessment. A suitably qualified assessor signs Part B. Microbiological evidence is an input to this review, not a substitute for the complete dossier. The responsible person must provide correct information and keep the assessment current.
For a brand, the practical question is not simply whether a supplier can produce a document headed “microbiology.” Ask what was tested, which formulation and batch it represents, what method was used, and how the results inform the safety conclusion. A report for a different fragrance, preservative system or packaging configuration may need further evaluation.
Microbial quality versus challenge testing: what is the difference?
A microbial-quality examination assesses the submitted sample against defined microbiological criteria. A preservation efficacy or challenge test examines antimicrobial protection under a specified test protocol. These answer different questions: an acceptable sample at one point does not, by itself, establish adequate preservation throughout foreseeable use.
ISO 11930:2019 describes evaluation of cosmetic antimicrobial protection using preservation-efficacy data, microbiological risk assessment, or both. Its public scope distinguishes products established as microbiologically low risk and references ISO 29621. Ask the laboratory to identify the edition, amendments and method suitability it will apply. Do not turn a standard number into an unsupported claim of product approval.
| Evidence stream | Question it addresses | Brand review point |
|---|---|---|
| Microbial quality examination | What was found in the submitted sample? | Confirm sample identity, method, criteria and results |
| Preservation efficacy assessment | How does the formulation perform under the specified challenge protocol? | Obtain the complete report and interpretation |
| Microbiological risk assessment | How do formula, use and packaging affect risk? | Require documented reasoning, not a marketing claim |
| Manufacturing controls | How is consistent quality maintained? | Review relevant specifications and quality records |
Does every cosmetic need exactly the same test?
No single purchasing checklist should be applied without considering the product. The ISO scope expressly recognizes a low-risk assessment route. However, “water-free,” “natural,” “alcohol-based” or “airless” is not, on its own, a complete justification for omitting evidence. Have the assessor and laboratory evaluate the actual composition, manufacturing conditions, intended use and package.
As a project-control recommendation, record the reason for every test included or excluded. If a supplier says a challenge test is unnecessary, ask for the technical basis and who has accepted that basis for the finished product. Do not substitute a sales email for a documented decision. This article does not prescribe organism counts or pass/fail limits: the laboratory should specify the applicable criteria for the actual product and method.
How should a brand organize the testing process?
- Define the finished formula, intended users, use site, instructions and final packaging.
- Share the relevant composition and supplier information with the assessor under an appropriate confidentiality arrangement.
- Agree the test scope, methods, acceptance criteria, sample quantities and report deliverables with the laboratory.
- Send traceable, representative samples with batch and formula-version identifiers.
- Resolve abnormal results and deviations before relying on a report.
- Have the evidence reviewed within the CPSR and retained with the product documentation.
- Define which later changes trigger reassessment.
This recommended sequence avoids paying for a test on a prototype that is subsequently reformulated. It also separates sample testing from the commercial decision to order packaging or launch advertising. Link it to your broader EU cosmetic launch plan.
How long does the microbiology work take?
There is no reliable universal turnaround promise for every formula and laboratory. Protocol duration, sample preparation, laboratory scheduling, method suitability, repeat work and assessor review can all affect the completion date. Obtain a written schedule and ask whether it includes the final signed report or only completion of laboratory observations.
| Project stage | Dependency | Release decision |
|---|---|---|
| Before sample submission | Formula and test brief agreed | Laboratory accepts scope and samples |
| During testing | Protocol observations and quality checks | Do not treat interim observations as final clearance |
| Report review | Complete results and resolved deviations | Assessor evaluates relevance and adequacy |
| Before commercial release | Required safety documentation and other market duties complete | Responsible person confirms readiness |
For budgeting, request separate prices for initial testing, additional variants, retests, sample shipping and assessment work. These are procurement questions, not official government fees. A low quote can be misleading if it excludes the interpretation or documentation your project needs.
What should a manufacturer provide?
The HPRA cosmetic GMP guide addresses documented microbiological testing procedures and records, where applicable, and handling of out-of-specification product. Ask your manufacturing partner for the records relevant to your order, rather than assuming a factory certificate establishes each finished product’s safety.
A practical supplier request can include the final formula identifier, ingredient information, available microbiological reports, batch documentation, product specification, relevant manufacturing controls and information about the final container. Confirm which records are already available, which tests must be commissioned, who pays for them and who receives the full reports. Do not claim that MOOYAM or a supplier has performed a particular test unless the exact report has been confirmed.
What remains the brand owner’s responsibility?
The brand should communicate intended markets, claims, consumer group, usage instructions and proposed packaging, and coordinate changes with the EU responsible person. Agree document ownership and access before production. A laboratory measures and reports within its scope; the safety assessor interprets safety evidence; the responsible person carries the applicable regulatory responsibilities. Commercial outsourcing does not make these roles interchangeable.
Which mistakes should purchasing teams avoid?
- Accepting a summary “pass” without the product identity, method and full result record.
- Using an old report after a formula change without assessing its continued relevance.
- Confusing preservative efficacy with routine batch quality testing.
- Using a laboratory image or report template to imply a test has actually been completed.
- Booking a launch before open safety questions have been resolved.
Frequently asked questions
Is a microbiology report an EU approval certificate?
No. It supplies evidence for defined questions. It does not replace the complete safety assessment or the remaining market-entry obligations.
Can a preservative supplier’s data replace finished-product testing?
Do not assume that it can. The finished formula and use conditions must be considered; have the assessor determine whether the evidence is applicable and sufficient.
Can a low-risk product omit a challenge test?
A justified microbiological risk assessment may support an appropriate route. It is not a blanket exemption based on a product’s marketing category.
Should a changed fragrance be reviewed?
Yes. Submit the change for technical review so the relevant experts can decide whether existing evidence still applies or additional work is needed.
What if the report contains an unexpected result?
Do not hide it or simply replace the report. Ask the laboratory, manufacturer and assessor to investigate, document the conclusion and determine appropriate next steps before release.
Plan your documentation before production
MOOYAM provides cosmetic OEM/ODM manufacturing and technical documentation support for international beauty brands. Discuss your formula, packaging and market with our OEM/ODM team, or request a project discussion to confirm available records and any additional testing needs.
Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or qualified compliance professional before placing cosmetic products on the market.